Eurofins Assurance obtains EXCiPACT Certification Body approval for pharmaceutical excipient certification

29 August 2025, Hong Kong

The Eurofins Assurance network of companies is pleased to announce that it has obtained EXCiPACT Certification Body approval for Good Manufacturing Practice (GMP), Good Distribution Practice (GDP) and Good Warehousing Practice (GWP) audits, enabling it to further contribute to safeguarding the quality of excipients used in the pharmaceutical industry for drug manufacturing.

EXCiPACT is a global non-profit organization responsible for owning and managing the independent EXCiPACT certification scheme. This scheme encompasses various components centered around GMP, GDP and GWP, all designed to ensure the highest quality of excipients, which are essential components in pharmaceutical manufacturing.

The Eurofins Assurance network is proud to be the eighth recipient of EXCiPACT’s Certification Body approval. This achievement highlights the Eurofins Assurance network’s robust certification service offering and audit capabilities, commitment to excellence, and adherence to industry standards.

Thanks to this official recognition, Eurofins Assurance companies can further support excipient users and suppliers to achieve certification based on a harmonised standard, and demonstrate compliance in a highly regulated industry through a streamlined audit process.

Learn more about the Eurofins Assurance network’s services below:

https://www.eurofins.com/assurance/excipact-certification/